BofA analysts believe that these small cap value stocks are poised to benefit from accelerating profit growth and could outperform in a scenario where the Federal Reserve ceases to hike interest rates.
Atmus Filtration Technologies' P/S ratio may not be justified due to forecasted revenue decline. Market's disregard for analysts' pessimistic outlook could lead to unsustainable prices. Declining revenues may eventually impact share price.
ACT Research released preliminary NA truck net orders for July 2023. Class 8 net orders were 16,000 units, down 5% MoM and up 45% YoY (on an easy compare). Seasonally adjusted net orders came in at 20,700 units (248,400 SAAR), up 5.5% MoM. July tends to be a seasonally weak month for orders, and order activity was in-line with ACT Research’s expectations. Per ACT, the July data implies Class 8...
Gapping up $Atmus Filtration Technologies (ATMU.US)$+2.70% (Shares of the air filtration company rose after a slew of analysts initiated coverage with bullish ratings, including JPMorgan. The bank said Atmus trades at a "deep discounted valuation vs. peers, despite >80% of aftermarket mix, while its planned expansion into industrial filtration should bridge the valuation gap vs. direct filtration peers over time.") $DICE THERAPEUTICS, INC. (DICE.US)$+37.70%...
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Atmus Filtration Technologies Stock Forum
$Atmus Filtration Technologies (ATMU.US)$+2.70% (Shares of the air filtration company rose after a slew of analysts initiated coverage with bullish ratings, including JPMorgan. The bank said Atmus trades at a "deep discounted valuation vs. peers, despite >80% of aftermarket mix, while its planned expansion into industrial filtration should bridge the valuation gap vs. direct filtration peers over time.")
$DICE THERAPEUTICS, INC. (DICE.US)$+37.70%...
what do we have here maybe a short
No comment yet